| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | +3.0% | -24.1% |
| Cost of Revenue | $700K | — | -35.4% |
| Gross Profit | $983K | +12.0% | -13.4% |
| R&D Expense | $264K | — | — |
| SG&A Expense | $2.5M | +12.6% | +192.9% |
| Operating Income | -$1.5M | — | — |
| Pre-tax Income | -$1.3M | +4.1% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $28.2M | — | — |
| Accounts Receivable | $1.5M | — | — |
| Current Assets | $30.9M | — | — |
| Total Assets | $31.6M | — | — |
| Current Liabilities | $1.9M | +932.5% | +1232.4% |
| Total Liabilities | $2.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.2M | — | — |
| Capital Expenditures | $38K | — | — |
| Investing Cash Flow | -$31K | — | — |
| Financing Cash Flow | $29.2M | — | — |
| Free Cash Flow | -$3.3M | — | — |
| -791.5% |
| Income Tax | $1K | — | — |
| Net Income | -$1.3M | — | — |
| EPS (Basic) | -$0.02 | — | — |
| EPS (Diluted) | -$0.02 | — | — |
| +1368.5% |
| Stockholders' Equity | $29.5M | — | — |